RSS Feed For (NASDAQ:VNDA)

VANDA PHARMA (NASDAQ:VNDA)

10.42 -0 (-0%)
VANDA PHARMA (NASDAQ:VNDA) Delayed :
Previous Close $10.42    52 Week High $16.65 
Open $10.37    52 Week Low $0.45 
Day High $10.53    P/E N/A 
Day Low $10.28    EPS $-1.27 
Volume 443,778       
More VNDA Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
VICL 3 HT 3
LEA 2 PRTS 2
NVS 2 CVO 2
TBSI 2 COF 2
THQI 2 ECLP 2
TRW 2 NSHA 2
View All Friends, Peers and Foes

StreetInsider Reports on VNDA by Category

Comments on recent VNDA articles

Oliver
on May 13, 2009
at 11:30 PM
Future Not So Hot... I don't think this is a good sign when executives are getting rid of all their shares. SELL!!!!!
Article: Vanda Pharma (VNDA) Executives Cash Out Following 1000% Surge In The Stock After FDA Okay
jw
on May 8, 2009
at 10:20 PM
www.primalbid.com PrimalBid is your source for 20%-40% savings, or more off the products and services your company already uses each and every day. In this economy especially, why not let sellers compete against themselves for your business? Our system is simple. As a buyer you register with PrimalBid for Free. Next, you enter the product or service your are looking to purchase; then that’s where we come in. PrimalBid’s system is a blind reverse auction, so you are completely in control. The only time a seller knows if they are winning the bid is if they are in the Top Spot for the product or service. This insures each seller puts in their best price. Best of all the price you see on the winning bid is the price you pay.
Article: Top 10 News Items 5/4-5/8: Bank Stress Test Results Released: BofA, Citi, Wells Fargo Need More Capital; Unemployment Rate Just Under 9%; Retailers Issue April Sales Results
jlm
on May 6, 2009
at 07:24 PM
vanda after hours! so unfair! retail investors left out again.
Article: Vanda Pharmaceuticals (VNDA) Surges 900% On FDA Approval For its Drug
KongPong
on Aug 11, 2008
at 02:36 PM
VNDA VNDA going down. http://www.streetinsider.com
Article: Vanda Pharma (VNDA) Announces FDA Not Approvable Letter for Iloperidone

Comments on VNDA


No comments are currently available.